Skip to main content
Springer logoLink to Springer
. 2013 Jun 27;32(12):1579–1582. doi: 10.1007/s10096-013-1913-x

A subset of two adherence systems, acute pro-inflammatory pap genes and invasion coding dra, fim, or sfa, increases the risk of Escherichia coli translocation to the bloodstream

K Szemiako 1, B Krawczyk 1, A Samet 2, A Śledzińska 2, B Nowicki 3, S Nowicki 3, J Kur 1,
PMCID: PMC3825633  PMID: 23801304

Abstract

An analysis of the phylogenetic distribution and virulence genes of Escherichia coli isolates which predispose this bacteria to translocate from the urinary tract to the bloodstream is presented. One-dimensional analysis indicated that the occurrence of P fimbriae and α-hemolysin coding genes is more frequent among the E. coli which cause bacteremia. However, a two-dimensional analysis revealed that a combination of genes coding two adherence factors, namely, P + Dr, P + S, S + Dr, S + fim, and hemolysin + one adherence factor, were associated with bacteremia and, therefore, with the risk of translocation to the vascular system. The frequent and previously unrecognized co-existence of pro-inflammatory P fimbriae with the invasion promoting Dr adhesin in the same E. coli isolate may represent high-risk and potentially lethal pathogens.


Escherichia coli, the predominant facultative organism of the intestinal flora, can cause severe extra-intestinal infections, including infection of the kidney (pyelonephritis) or bloodstream (bacteremia). When it escapes from its usual habitat, E. coli can colonize the genital tract and, as a subsequent step, ascend to the bladder and kidneys. Ascending urinary tract infection (UTI) is well explained by tissue receptor–E. coli adhesins interactions. Several E. coli virulence factors, including toxins, are implicated in renal inflammatory injury and bacteremia, but the mechanisms of translocation from the renal system to the bloodstream is poorly understood. It is thought that the strains which cause extra-intestinal infections harbor virulence factors that enhance the ability of E. coli to cause systemic infection. While an increase in the occurrence of E. coli bacteremia and urosepsis has been reported in recent years, relatively few studies have investigated the characteristics of the E. coli strains causing bacteremia. In fact, reports on the association between the risk of bacteremia/septicemia and occurrence of E. coli virulence factors are contradictory. While some studies propose that P fimbriae and α-hemolysin are associated with the risk of bacteremia [1], others indicate that there is no such association and that E. coli virulence factors do not differ between those isolated from bacteremia and those isolated from pyelonephritis [2].

UTIs affect from 5 to 36 % of renal transplant (RT) patients. In these patients, UTI is a frequent cause of bacteremia, septicemia, and acute graft failure [3]. E. coli is the most common etiologic agent of UTI in RT patients, as well as being the most frequent pathogen isolated from RT recipients with bacteremia [4]. To date, only a few studies have been available regarding the phylogenetic and virulence characteristics of E. coli isolates causing UTI and bacteremia in severely immunosuppressed patients, such as RT recipients [57].

Uropathogenic E. coli (UPEC) strains have particular phenotypic features which facilitate their persistence in urinary tracts and differentiate them from the other pathogenic and commensal E. coli strains. UPEC strains encode a number of virulence factors which enable the bacteria to colonize the urinary tract and persist in the face of a highly effective host defense. UPEC isolates exhibit a high degree of genetic diversity, owing to the possession of specialized virulence genes located on mobile genetic elements, called pathogenicity islands [8]. The virulence factors of E. coli which have been potentially implicated as important in establishing UTIs can be divided into two groups: (i) virulence factors associated with the surface of the bacterial cell and (ii) virulence factors which are secreted and exported to the site of action [9]. The surface virulence factors of UPEC include a number of different types of adhesive organelles (fimbriae), which promote bacterial attachment to, and/or invasion of, host tissues within the urinary tract, namely, type 1, P, S, and Dr adhesins [10]. For example, type 1 fimbriae mediate invasion of the bladder tissue, form intracellular bacterial communities, and are implicated in recurrent cystitis [10]. P fimbriae induce acute inflammatory signaling and are associated with acute pyelonephritis, while Dr adhesins promote cellular invasion and are associated with chronic pyelonephritis [11]. Interestingly, both adhesins are only carried by the same E. coli strain occasionally. The most important secreted virulence factors are a lipoprotein called α-hemolysin (HlyA), the cytotoxic necrotizing factor 1 (CNF1), and the uropathogenic specific protein (USP) [12]. In addition, phylogenetic analyses have revealed that UPEC strains differ substantially from other E. coli strains. Pathogenic E. coli strains, including UPEC strains, mainly belong to phylogenetic group B2 and, to a lesser extent, group D, the ‘high-virulence’ groups, whereas isolates of groups A or B1, the ‘low-virulence’ groups, contain few virulence determinants and are usually regarded as commensals [13].

The aim of this study was to gain insight into the phylogenetic distribution and virulence genes of E. coli isolates predisposing the translocation of E. coli from the urinary tract to the bloodstream in RT patients. We consider that the inconsistent findings on the association of individual virulence factors with the translocation to the bloodstream may result from the fact that E. coli require a battery of different adherence factors, in combination, in order to access the vascular bed. For example, we recently reported a case of maternal death owing to E. coli septicemia, where E. coli bearing both P and Dr adhesins spread from the kidney to the blood, causing lethal septic shock [14]. To investigate E. coli factors predisposing RT patients with UTIs to bacteremia, we performed an analysis of individual E. coli virulence factors in RT versus non-RT bacteremia and then conducted a two-dimensional analysis of all the virulence factors in all the groups tested.

The study population constituted 67 patients who had developed E. coli UTI and/or bacteremia and were hospitalized by the Department of Nephrology, Transplantology and Internal Diseases at the Gdańsk University of Medicine in Poland during the period from 2006 to 2009. The criteria for inclusion isolates in this study were based on the genotyping of isolates using the PCR MP and REA-PFGE methods [15]. A total of 215 isolates were genotyped, of which 103 strains came from blood and 112 were isolated from urine. The strains isolated from the same material among particular patients identified as the same genotype were rejected from the study. The genetic criteria for urinary tract and bloodstream transmission of the E. coli isolate were that of identical fingerprint profiles with at least one identical genotype isolated from the urine and the blood. A total of 77 E. coli isolates met the inclusion criteria and they were divided into four groups: (I) 44 blood isolates from non-RT patients with positive urine culture and bacteremia, (II) 19 blood isolates from RT patients with positive urine culture and bacteremia, (III) six isolates from non-RT patients with positive urine culture but no bacteremia, and (IV) eight isolates from RT patients with positive urine culture but no bacteremia.

Multiplex PCR-based methods were used to determine the presence of six virulence factors genes, as previously described [16]. They included fimG/fimH (genes of type 1 fimbriae), sfaD/sfaE (genes of S fimbriae), papC (gene of P fimbriae), hlyA (gene encoding α-hemolysin), cnf1 (gene encoding cytotoxic necrotizing factor 1), and usp (gene encoding uropathogenic specific protein). The isolates were also examined by PCR assay for the presence of the genes encoding fimbriae of the Dr family, afa/dra(B-C), as described previously [17]. Statistical analysis of the results was carried out using a Chi-square test. The probability threshold p-value was assumed to be at the level of 0.05.

The one-dimensional analysis (Table 1) carried out on the pool of selected strains from all patients shows that bacteriocin Usp was the most frequently occurring virulence factor. Gene usp was carried by 90 % of the bacteremia strains which were able to translocate to the blood (groups I and II) and 71 % among strains with no bacteremia and no translocation (groups III and IV). Despite its higher frequency in blood, the presence of the usp gene was not statistically significant (p = 0.551). The occurrence of only two individual factors, P fimbriae (p = 0.006) and α-hemolysin (p = 0.007), out of the seven virulence factors being investigated was statistically more frequent among E. coli isolates from bacteremia. The one-dimensional analysis thus suggests that P fimbriae and α-hemolysin are the virulence factors which may predispose E. coli strains to migrate from the urinary tract to the bloodstream. Surprisingly, the occurrence of Dr adhesin among all the bacteremic E. coli (80 %) and in the RT patients (53 %) was both very high and much higher than previously reported [2]. Despite the overall high frequency, the blood isolates from RT patients were characterized by a lower rate of individual virulence genes, such as, for example, Dr adhesins (p = 0.03). A high frequency of genes coding S fimbriae (70 %) was also observed, but there was no difference between the groups being tested.

Table 1.

Unidirectional analysis of PCR-based detection n = of genes encoding the examined E. coli virulence factors

Virulence factora Translocation groups I + II (n = 63) vs. no translocation groups III + IV (n = 14) RT translocation group II (n = 19) vs. non-RT translocation group I (n = 44) RT total groups II + IV (n = 27) vs. non-RT total groups I + III (n = 50)
% p-value % p-value % p-value
P 62/21 0.006 58/64 0.667 44/60 0.191
S 71/50 0.121 74/70 0.795 70/66 0.696
cnf 46/36 0.482 37/50 0.336 37/48 0.355
usp 90/71 0.551 84/93 0.266 78/92 0.076
fim 76/57 0.148 68/80 0.341 59/80 0.051
hly 46/7 0.007 37/50 0.336 30/44 0.217
dr 71/64 0.597 53/80 0.030 52/80 0.010

Group I translocation non-RT [blood(+)/urine(+)] 44 E. coli

Group II translocation RT [blood(+)/urine(+)] 19 E. coli

Group III no translocation non-RT [blood(−)/urine(+)] 6 E. coli

Group IV no translocation RT [blood(−)/urine(+)] 8 E. coli

a P P fimbriae (papC), S S fimbriae (sfaD/sfaE), cnf cytotoxic necrotizing factor (cnf1), usp bacteriocin usp, fim type 1 fimbriae (fimG/fimH), hly α-hemolysin (hlyA), dr Dr fimbriae (afa/dra B–C)

As pathogenic E. coli often carry multiple adherence factors, a two-dimensional data analysis was performed (Table 2). Consistent with our hypothesis, a combination of two adherence factors was associated with bacteremia/translocation to the blood. This included combinations of P + Dr and S + Dr, but not type 1 + Dr (p-values 0.022, 0.036, and 0.452, respectively). We observed that the strains which carry genes coding type 1 fimbriae and α-hemolysin simultaneously were also associated with bacteremia (p = 0.005). This suggests that a combination of this kind could also be a predictive factor for the risk of translocation. The two-dimensional analysis demonstrated that the strain’s blood transmission was not statistically associated with the presence of such virulence factors as a cytotoxic necrotizing factor coexisting with P, S, Dr, or type 1 fimbriae or with bacteriocin Usp (p-values 0.237, 0.276, 0.384, 0.199, and 0.481, respectively). The risk of translocation was also not correlated with the coexistence of Dr fimbriae and bacteriocin Usp or type 1 fimbriae (p = 0.384 and p = 0.24, respectively). In contrast to bacteremia versus non-bacteremia, where significant differences were observed, we identified no significant differences between E. coli virulence factors from RT and non-RT patients. The reason for the lower frequency of Dr adhesins in RT patients is not clear and may be associated with immunosuppression or, perhaps, the stage of renal disease and/or function, which may require independent evaluation.

Table 2.

Two-dimensional analysis of the coexistence of two genes encoding virulence factors among the investigated E. coli isolates

Virulence factora Translocation groups I + II (n = 63) vs. no translocation groups III + IV (n = 14) RT translocation group II (n = 19) vs. non-RT translocation group I (n = 44) RT total groups II + IV (n = 27) vs. non-RT total groups I + III (n = 50)
% p-value % p value % p value
P + S 56/21 0.021 53/57 0.759 41/54 0.267
P + cnf1 38/21 0.237 26/43 0.206 22/42 0.083
P + usp 62/21 0.006 59/64 0.667 44/60 0.191
P + fim 48/7 0.005 42/50 0.565 30/46 0.162
P + hly 38/7 0.025 37/39 0.893 30/34 0.696
P + dr 48/14 0.022 32/55 0.094 26/50 0.041
S + cnf 44/29 0.276 37/48 0.425 33/46 0.282
S + usp 70/43 0.056 74/68 1.662 67/64 0.815
S + fim 59/21 0.011 58/59 0.929 48/54 0.624
S + hly 38/7 0.025 32/41 0.484 26/36 0.368
S + dr 52/21 0.036 37/59 0.105 33/54 0.083
cnf + usp 46/36 0.481 37/50 0.336 37/48 0.355
cnf + fim 40/21 0.199 32/43 0.388 30/40 0.367
cnf + hly 35/7 0.040 21/41 0.129 19/36 0.110
cnf + dr 33/21 0.384 16/41 0.052 19/38 0.078
usp + fim 76/50 0.050 68/80 0.341 59/78 0.082
usp + hly 46/7 0.007 37/50 0.336 30/44 0.217
usp + dr 67/50 0.240 47/75 0.033 44/74 0.010
fim + hly 38/0 0.005 26/43 0.206 19/38 0.078
fim + dr 54/43 0.452 37/61 0.073 30/64 0.004
hly + dr 38/7 0.025 21/45 0.067 19/40 0.055

a P P fimbriae (papC), S S fimbriae (sfaD/sfaE), cnf cytotoxic necrotizing factor (cnf1), usp bacteriocin usp (usp), fim type 1 fimbriae (fimG/fimH), hly α-hemolysin (hlyA), dr Dr fimbriae (afa/dra B–C)

The phylogenetic group analysis was determined by a triplex PCR assay performed with a combination of three DNA markers (chuA, yjaA, and the DNA fragment TSPE4.C2), as previously described [18]. As expected, group B2 was associated with the presence of classic virulence factor genes, whereas group B1 isolates had the lowest virulence factor score. In our analysis, phylogenetic E. coli groups A, B1, B2, and D for the RT recipients’ isolates being tested (groups II and IV) accounted for 0 %, 33 %, 57 %, and 10 % of the isolates, respectively. In the isolates from the non-RT patients (groups I and III), phylogenetic groups A, B1, B2, and D accounted for 0 %, 16 %, 84 %, and 0 %, respectively. The shift from group B2 toward group B1 observed could, thus, account for the lower frequency of virulence factor genes among RT isolates when compared with those from non-RT patients.

To summarize, in this paper, we have reported that E. coli translocation to the bloodstream was associated with a high frequency combination of two adherence factors, namely, P, and Dr, S, or Type 1 adhesins. P mediates acute inflammatory signaling, while Dr, S, and Type 1 may mediate tissue invasion. This observation implies that E. coli bearing P fimbriae with the capacity to cause severe inflammatory response and an adhesin which can mediate tissue invasion may establish an effective translocation strategy for passing all tissue barriers in order to access the bloodstream and cause bacteremia. An unrecognized combination of P and Dr adhesins may contribute to the establishment of a clonal group of a super-pathogenic E. coli, which, if combined with resistance to antibiotics, may represent a new trend in the evolution of uropathogens.

Acknowledgments

This work was supported by the Polish Ministry of Science and Higher Education Grant No. N401331239, awarded to A.Ś and in part by U54 RR026140 (NCRR)/U54 MD007593 (NIMHD).

Conflict of interest

The authors declare that they have no conflict of interest.

References

  • 1.Brauner A, Katouli M, Östenson CG. P-fimbriation and haemolysin production are the most important virulence factors in diabetic patients with Escherichia coli bacteraemia: a multivariate statistical analysis of seven bacterial virulence factors. J Infect. 1995;31:27–31. doi: 10.1016/S0163-4453(95)91271-1. [DOI] [PubMed] [Google Scholar]
  • 2.Moreno E, Planells I, Prats G, Planes AM, Moreno G, Andreu A. Comparative study of Escherichia coli virulence determinants in strains causing urinary tract bacteremia versus strains causing pyelonephritis and other sources of bacteremia. Diagn Microbiol Infect Dis. 2005;53:93–99. doi: 10.1016/j.diagmicrobio.2005.05.015. [DOI] [PubMed] [Google Scholar]
  • 3.Barbouch S, Cherif M, Ounissi M, Karoui C, Mzoughi S, Hamida FB, Abderrahim E, Bozouita A, Abdalla T, Kheder A. Urinary tract infections following renal transplantation: a single-center experience. Saudi J Kidney Dis Transplant. 2012;23:1311–1314. doi: 10.4103/1319-2442.103586. [DOI] [PubMed] [Google Scholar]
  • 4.Pinheiro HS, Mituiassu AM, Carminatti M, Braga AM, Bastos MG. Urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in kidney transplant patients. Transplant Proc. 2010;42:486–487. doi: 10.1016/j.transproceed.2010.02.002. [DOI] [PubMed] [Google Scholar]
  • 5.Bert F, Huynh B, Dondero F, Johnson JR, Paugam-Burtz C, Durand F, Belghiti J, Valla D, Moreau R, Nicolas-Chanoine MH. Molecular epidemiology of Escherichia coli bacteremia in liver transplant recipients. Transpl Infect Dis. 2011;13:359–365. doi: 10.1111/j.1399-3062.2011.00618.x. [DOI] [PubMed] [Google Scholar]
  • 6.Rice JC, Peng T, Kuo YF, Pendyala S, Simmons L, Boughton J, Ishihara K, Nowicki S, Nowicki BJ. Renal allograft injury is associated with urinary tract infection caused by Escherichia coli bearing adherence factors. Am J Transplant. 2006;6:2375–2383. doi: 10.1111/j.1600-6143.2006.01471.x. [DOI] [PubMed] [Google Scholar]
  • 7.Johnson JR, Johnston B, Clabots C, Kuskowski MA, Pendyala S, Debroy C, Nowicki B, Rice J. Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients. Antimicrob Agents Chemother. 2010;54:546–550. doi: 10.1128/AAC.01089-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Oelschlaeger TA, Dobrindt U, Hacker J. Pathogenicity islands of uropathogenic E. coli and the evolution of virulence. Int J Antimicrob Agents. 2002;19:517–521. doi: 10.1016/S0924-8579(02)00092-4. [DOI] [PubMed] [Google Scholar]
  • 9.Emody L, Kerényi M, Nagy G. Virulence factors of uropathogenic Escherichia coli. Int J Antimicrob Agents. 2003;22:29–33. doi: 10.1016/S0924-8579(03)00236-X. [DOI] [PubMed] [Google Scholar]
  • 10.Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. Intracellular bacterial biofilm-like pods in urinary tract infections. Science. 2003;301:105–107. doi: 10.1126/science.1084550. [DOI] [PubMed] [Google Scholar]
  • 11.Selvarangan R, Goluszko P, Singhal J, Carnoy C, Moseley S, Hudson B, Nowicki S, Nowicki B. Interaction of Dr adhesin with collagen type IV is a critical step in Escherichia coli renal persistence. Infect Immun. 2004;72:4827–4835. doi: 10.1128/IAI.72.8.4827-4835.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bien J, Sokolova O, Bozko P. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol. 2012;2012:681473. doi: 10.1155/2012/681473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bingen-Bidois M, Clermont O, Bonacorsi S, Terki M, Brahimi N, Loukil C, Barraud D, Bingen E. Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect Immun. 2002;70:3216–3226. doi: 10.1128/IAI.70.6.3216-3226.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Śledzińska A, Mielech A, Krawczyk B, Samet A, Nowicki B, Nowicki S, Jankowski Z, Kur J. Fatal sepsis in a pregnant woman with pyelonephritis caused by Escherichia coli bearing Dr and P adhesins: diagnosis based on postmortem strain genotyping. BJOG. 2011;118:266–269. doi: 10.1111/j.1471-0528.2010.02732.x. [DOI] [PubMed] [Google Scholar]
  • 15.Krawczyk B, Samet A, Leibner J, Śledzińska A, Kur J. Evaluation of a PCR melting profile technique for bacterial strain differentiation. J Clin Microbiol. 2006;44:2327–2332. doi: 10.1128/JCM.00052-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Adamus-Białek W, Wojtasik A, Majchrzak M, Sosnowski M, Parniewski P. (CGG)4-Based PCR as a novel tool for discrimination of uropathogenic Escherichia coli strains: comparison with enterobacterial repetitive intergenic consensus-PCR. J Clin Microbiol. 2009;47:3937–3944. doi: 10.1128/JCM.01036-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Le Bouguenec C, Archambaud M, Labigne A. Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction. J Clin Microbiol. 1992;30:1189–1193. doi: 10.1128/jcm.30.5.1189-1193.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000;66:4555–4558. doi: 10.1128/AEM.66.10.4555-4558.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from European Journal of Clinical Microbiology & Infectious Diseases are provided here courtesy of Springer

RESOURCES